Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not listed as a common cause of numbness or tingling in the official prescribing information, and these sensations are not among the recognised frequent side effects. That said, some people starting treatment do report them, and working out why matters — because the explanation is rarely the medicine itself. Numbness and tingling have several possible causes that overlap with the population taking tirzepatide, from rapid blood-sugar changes to compressed nerves, and each deserves a different response. These are prescription-only medicines; a GPhC-registered prescriber should hear about any new symptom that persists or concerns you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Check the Mounjaro Patient Information Leaflet (you can find the full list on the Mounjaro SmPC on the eMC) and you won't see peripheral numbness or tingling under the common or very common side effect categories. The recognisable side-effect picture for tirzepatide is dominated by the gut: nausea, vomiting, diarrhoea, constipation and indigestion tend to peak around a dose increase and settle within a fortnight for most people, and if you're wondering whether Mounjaro can cause IBS, that question is explored in detail on its own page. That's worth keeping in mind when something different, like a pins-and-needles feeling in the hands or feet, appears. It's outside the expected pattern, which means it warrants a closer look rather than quiet acceptance.
The NHS medicines page for tirzepatide lists the side effects to watch for and flags which need urgent attention. Sensory changes (particularly anything affecting one side of the body, or accompanied by weakness or difficulty speaking) are always in the urgent category, regardless of what medicine you're taking.
That leaves the question of why some people on Mounjaro do notice tingling. The answers are almost always about what's happening alongside the treatment, not because of the drug itself. More on that below.
This is the explanation that most prescribers reach for first, especially in the early weeks. Tirzepatide works partly by improving how the body manages blood sugar, a dual GIP and GLP-1 receptor agonist, it's the only licensed weight-loss medicine in the UK acting on both pathways. For people whose glucose levels were running high before treatment, a meaningful drop can cause temporary nerve sensitivity. Hypoglycaemia (low blood sugar) is itself a recognised cause of tingling, especially around the mouth and in the fingers.
People with type 2 diabetes, prediabetes or metabolic syndrome are well represented among those taking Mounjaro for weight management. If your blood sugar was elevated before you started, the adjustment period can produce sensory changes that feel alarming but are often short-lived. A quick check: if the tingling comes on suddenly, especially alongside shakiness, sweating or confusion, check your blood sugar straight away if you have a monitor. That's a one-minute habit that can tell you a great deal.
If you're curious how tirzepatide compares with the wider effects people notice on it, the full side-effect picture is worth reading alongside this page.
Peripheral neuropathy (the slow nerve damage associated with years of elevated blood sugar) is common in people with type 2 diabetes, and many cases go unnoticed until something changes. Starting a medicine that alters circulation, reduces inflammation or shifts body composition can sometimes bring existing nerve symptoms to the surface. This is one reason a prescriber will want your full medical history before approving treatment, not just your BMI.
Some people also experience something called treatment-induced neuropathy, a recognised phenomenon in diabetes care where a rapid improvement in blood-sugar control temporarily worsens neuropathy symptoms. It's counterintuitive, but it is documented in endocrinology literature. If you already have a diabetes diagnosis and notice new tingling in your feet or hands after starting tirzepatide, that's a specific conversation to have with your prescriber or GP rather than something to note and move on from.
For a detailed look at the related question of tingling specifically in the hands and feet, this page covers it directly. And if you've come across talk about Mounjaro and MS-like symptoms, the evidence on that is examined here.
Speed matters with certain neurological symptoms. Call 999 or go to A&E if you notice sudden numbness or weakness affecting one side of your face, arm or leg, that's a potential stroke and it's a medical emergency. Similarly, numbness after an injury, tingling that spreads rapidly, or any loss of bladder or bowel control alongside sensory changes needs urgent attention.
For symptoms that are bilateral (both sides), mild, and seem to track with dose changes or mealtimes, a same-day call to your prescriber or GP is the right first step. Don't wait weeks at a review appointment to mention it; put it in writing or call. Our aftercare team is available seven days a week if you're a nume patient and want to discuss a symptom before your next clinical review.
It's also worth knowing that you can report any suspected side effect, including one not listed on the leaflet, through the MHRA's Yellow Card scheme, that's how the evidence base on newer medicines like Mounjaro improves over time. A coldness or circulation-like sensation sometimes described alongside tingling is a separate but related question; there's a page looking at that specifically.
If you'd like to explore whether tirzepatide is clinically appropriate for you, speak to our prescribers via a free consultation, every review is done personally, the same day, by a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.